Silyl modification of biologically active compounds. 13. Synthesis, cytotoxicity and antibacterial action of N-methyl-N-(2-triorganylsiloxyethyl)-1, 2, 3, 4-tetrahydro (iso) …
…, S Grinberga, I Shestakova, V Nikolajeva…
Index: Zablotskaya, Alla; Segal, Izolda; Popelis, Yuris; Grinberga, Solveiga; Shestakova, Irina; Nikolajeva, Vizma; Eze, Daina Applied Organometallic Chemistry, 2013 , vol. 27, # 2 p. 114 - 124
Full Text: HTML
Citation Number: 3
Abstract
Functional groups containing silicon might provide lipophilicity to a drug, allowing it to pass the cell membrane by passive diffusion. This strategy has been successfully applied in the antitumour drug analogues silatecans (silicon-containing camptothecins)[1, 2] and silaplatins (cisplatin analogues),[3] the HIV-1 reverse transcriptase inhibitor TSAO-T [4] and the effective anabolic'silabolin'.[5] Some silicon-containing drugs have entered phase I or ...
Related Articles:
[Ferles, Miloslav; Silhankova, Alexandra; Kafka, Stanislav; Taufmann, Petr; Motacek, Tomas Collection of Czechoslovak Chemical Communications, 1983 , vol. 48, # l p. 1759 - 1764]
[Azzena, Ugo; Pisano, Luisa; Pittalis, Mario Heterocycles, 2004 , vol. 63, # 2 p. 401 - 409]
[Anderson; Belelli; Bennett; Buchanan; Casula; Cooke; Feilden; Gemmell; Hamilton; Hutchinson; Lambert; Maidment; McGuire; McPhail; Miller; Muntoni; Peters; Sansbury; Stevenson; Sundaramt Journal of Medicinal Chemistry, 2001 , vol. 44, # 22 p. 3582 - 3591]
[Ferles, Miloslav; Silhankova, Alexandra; Kafka, Stanislav; Taufmann, Petr; Motacek, Tomas Collection of Czechoslovak Chemical Communications, 1983 , vol. 48, # l p. 1759 - 1764]
[Lukevits; Segal; Zablotskaya; Germane Chemistry of Heterocyclic Compounds, 1996 , vol. 32, # 6 p. 682 - 688]